Patient Population: Adult
| Diagnosis | Common Pathogens | Drug(s) of First Choice | Alternative Drug(s) | Comments | Expected Duration |
|---|---|---|---|---|---|
|
Respiratory viruses S. pneumoniae Mycoplasma pneumoniae Chlamydia pneumoniae H. influenza |
OR Amoxicillin 1 g PO TID |
Consider influenza testing and treatment with oseltamivir Consider coverage for MRSA and/or Pseudomonas aeruginosa in patients with respiratory isolation of these organisms or receipt of parenteral |
5 days |
American Journal of Respiratory and Critical Care Medicine, Volume 200, Issue 7, 1 October 2019, Pages e45-e67, https://www.atsjournals.org/doi/full/10.1164/rccm.201908-1581ST